-
Kabul drug rehab clinic in ruins after Pakistan strikes on Afghanistan
-
Israel strikes Tehran, Beirut as Iraq pulled deeper into Mideast war
-
Georgia ready for rugby elite despite rare Portugal defeat
-
Doncic leads Lakers to sixth straight win, Spurs sink Clippers
-
Iran 'negotiating' with FIFA over moving World Cup games to Mexico: embassy
-
Gavaskar condemns Indian-owned franchise for signing Pakistan bowler
-
Cash handouts, fare hikes as Philippines battles soaring fuel costs
-
Alleged Bondi Beach killer's mother received death threats, court told
-
Venezuela end Italy fairytale to reach World Baseball Classic final
-
Sweden's prisons prepare to house young teens
-
Indonesia weighs response to price pressures from Middle East war
-
In Hollywood, AI's no match for creativity, say top executives
-
Sao Paulo AI policing nabs criminals, and a few innocents
-
Trump faces coalition of the unwilling on Iran
-
Nvidia chief expects revenue of $1 trillion through 2027
-
Nvidia making AI module for outer space
-
Migrant workers bear brunt of Iran attacks in Gulf
-
Former tennis world number 39 banned for doping
-
Kennedy Center board approves 2-year closure for renovation
-
US judge halts implementation of Trump vaccine overhaul
-
Afghanistan accuses Pakistan of deadly airstrike on drug rehab centre in Kabul
-
Iran footballers train with Australia club and say 'everything will be fine'
-
Trump asks China to delay Xi summit as Iran war rages
-
Multiple suicide bombers hit Nigeria's Maiduguri city after years of calm
-
Wolves fightback frustrates Brentford
-
Israel president says Europe should back fight against Hezbollah as troops operate in Lebanon
-
Israel president tells AFP Europe should back efforts to 'eradicate' Hezbollah
-
Equities rise on oil easing, with focus on Iran war and central banks
-
Mbappe set for Real Madrid return against Man City
-
Nvidia rides 'claw' craze with AI agent platform
-
Alleged narco trafficker makes first US court appearance
-
Neymar misses out as Endrick returns to Brazil squad
-
Afghanistan accuses Pakistan of killing civilians in Kabul strike
-
South Lebanon's Christian towns insist they are not part of Israel-Hezbollah war
-
Alleged narco trafficker Marset makes first US court appearance
-
Securing the Strait of Hormuz: Tactics and threats
-
Cuba hit by total blackout as US fuel blockade bites
-
'Buffy' reboot cancelled: Sarah Michelle Gellar
-
PSG will go for the kill against Chelsea: Dembele
-
Afghan govt accuses Pakistan after new strikes on Kabul
-
Chelsea huddle not meant to 'antagonise' says Rosenior
-
Talks towards international panel to tackle 'inequality emergency' begin at UN
-
Trump pushes for 'enthusiasm' from allies to secure Hormuz
-
US, China hold 'constructive' talks on trade, but Trump visit in doubt
-
Laporta's new Barca chapter begins with Newcastle clash
-
EU talks energy as oil price soars
-
Out-of-favour Livingstone says 'no-one cares' in England set-up
-
Rising star Antonelli says Chinese GP triumph 'starting point' for F1 success
-
Stagflation risk in US 'quite high': Nobel-winning economist Stiglitz
-
Israel army says ground assault against Hezbollah underway in Lebanon
Ghostwriters, polo shirts, and the fall of a landmark pesticide study
A flagship study that declared the weedkiller Roundup posed no serious health risks has been retracted with little fanfare, ending a 25-year saga that exposed how corporate interests can distort scientific research and influence government decision-making.
Published in Regulatory Toxicology and Pharmacology in 2000, the paper ranks in the top 0.1 percent of citations among studies on glyphosate -- the key ingredient in Roundup, owned by agri-giant Monsanto and at the center of cancer lawsuits worth billions of dollars.
In his retraction note last week, the journal's editor-in-chief, Martin van den Berg, cited a litany of serious flaws from failing to include carcinogenicity studies available at the time to undisclosed contributions by Monsanto employees and even questions around financial compensation.
Elsevier, the journal's Dutch publisher, told AFP in a statement that it upholds the "highest standards of rigor and ethics" and that "as soon as the current editor became aware of concerns regarding this paper a matter of months ago, due process began."
But it did not address the fact that concerns date back to 2002, when critics wrote to Elsevier about "conflicts of interest, lack of transparency, and the absence of editorial independence" at the journal, including specific worries about Monsanto.
The matter exploded into public view in 2017, when internal corporate documents released during litigation showed one of Monsanto's own scientists admitting to "ghostwriting."
Harvard University science historian Naomi Oreskes, who co-authored a paper this September detailing the extent of the "fraud" in the 2000 study, told AFP that while she was "very gratified" at the "long overdue" action, but warned that "the scientific community needs better mechanisms to identify and retract fraudulent papers."
"This is completely in alignment with what we were calling them out for at the time," Lynn Goldman, a pediatrician and epidemiologist at GWU who co-signed the 2002 letter, added to AFP.
- Polo shirts -
Two of the paper's three original authors have since died, while first author Gary Williams, a professor at New York Medical College, did not respond to AFP's request for comment.
Monsanto maintains it acted appropriately, and that its product is safe. "Monsanto's involvement with the Williams et al paper did not rise to the level of authorship and was appropriately disclosed in the acknowledgments."
The company declined to comment on internal emails that suggested otherwise, including one in which a Monsanto scientist asked a colleague whether "the team of people" who worked on the Williams paper and another study "could receive Roundup polo shorts as a token of appreciation for a job well done."
Glyphosate was brought to market as a herbicide in the 1970s and initially welcomed as less toxic than DDT.
But its soaring use -- especially after Monsanto introduced glyphosate-tolerant seeds that allowed it to be sprayed widely over crops -- drew increasing scrutiny in the 1990s, making the 2000 paper hugely influential.
According to Oreskes's research, it was cited as supporting evidence for glyphosate's safety by groups ranging from the Canadian Forest Service to the International Court of Justice, the US Congress and the European Parliamentary Research Service.
- Legal interest -
In 2015, the World Health Organization's International Agency for Research on Cancer classified glyphosate as "probably carcinogenic to humans."
Several countries have since moved to restrict or ban its use, including France, which has prohibited household applications. Bayer, which acquired Monsanto, said it would phase out Roundup for US residential use in 2023 in response to growing lawsuits.
Nathan Donley, a scientist with the Center for Biological Diversity, told AFP he does not expect the retraction to sway the US Environmental Protection Agency, now under the pro-agricultural-industry Donald Trump administration, which has thrown its weight behind Bayer in an ongoing Supreme Court case.
But "it could play a role in litigation that is moving forward in the US against the EPA's proposed decision to renew glyphosate," Donley told AFP, adding that European regulators might also take note.
For Donley and others, the deeper concern is that the case may be far from unique.
"I am sure there (are a) lot (of) such ghost-written and undeclared conflict papers in the literature, but they are very difficult to unearth unless one goes really deep in litigation cases," John Ioannidis, a Stanford University professor who founded the field of meta-research told AFP.
M.Vogt--VB